Senior Microbiologist
embecta
Senior Microbiologist
embecta
Manufactures insulin delivery devices worldwide
embecta is a global medical device company with a 100-year legacy in insulin delivery and diabetes care. Driven by innovation, purpose, and a commitment to improving lives, we are expanding our portfolio of solutions to serve even more patients, healthcare providers, and communities around the world.
Senior Microbiologist
We are seeking an experienced Microbiology / Sterilization professional to join our Dun Laoghaire manufacturing site, where quality, compliance, and patient safety are paramount.
In this role, you will be the subject‑matter expert for microbiology, ETO sterilization, GLP, and cleanroom standards, ensuring all products are manufactured in full compliance with regulatory and company requirements.
You will provide hands‑on technical expertise, partner closely with Quality and Manufacturing teams, and play a critical role in maintaining the site in a continuous state of inspection readiness.
This is an excellent opportunity for a Senior Microbiology professional who enjoys working in a regulated manufacturing environment, influencing quality outcomes, and ensuring the highest standards are consistently met throughout the duration of the contract.
This is a fully onsite role due to the hands-on nature of laboratory and cleanroom activities.
Key responsibilities:
Experience and Education
Why embecta:
Join a purpose-driven organization where you will contribute to high-quality, compliant products that improve patient outcomes, while working in a collaborative, quality-focused manufacturing site.
#LI-ONSITE
#LI-DF1
embecta is an Equal Opportunity/Affirmative Action Employer. We do not unlawfully discriminate on the basis of race, color, religion, age, sex, creed, national origin, ancestry, citizenship status, marital or domestic or civil union status, familial status, affectional or sexual orientation, gender identity or expression, genetics, disability, military eligibility or veteran status, or any other protected status.
Embecta designs, manufactures, and sells insulin delivery devices such as pen needles, insulin syringes, and safety injection devices for diabetes patients around the world. Its products are used to inject insulin and include disposable components like Nano and Ultra-Fine needles, with a tubeless insulin patch pump once pursued but later refocused on core injection devices. The company differentiates itself as a dedicated diabetes injection devices supplier with a global manufacturing footprint and an established distribution network, originating as a BD spin-off. Embecta aims to grow through strategic expansion, including an announced plan to acquire Owen Mumford to broaden into drug-delivery platforms beyond diabetes.
Explore more opportunities at embecta